Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CC-401 is a potent inhibitor of all three JNK isoforms (Ki values range from 25 to 50 nM).1,2 It has at least 40-fold selectivity for JNK compared with other related kinases. CC-401 is bioavailable when delivered by gavage, blocking JNK signaling and renal fibrosis in a rat obstructed kidney model.2 It also has been shown to decrease hepatic necrosis and apoptosis after orthotopic liver transplantation and prevent acute renal failure following ischemia/reperfusion associated with renal transplantation in rats.1,3
WARNING This product is not for human or veterinary use.
1. c-
2. A pathogenic role for c-
3. JNK signalling in human and experimental renal ischaemia/reperfusion injury. Nephrol. Dial. Transplant 25(9), 2898-2908 (2010).